Nuveen, LLC Compass Therapeutics, Inc. Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
A detailed history of Nuveen, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 259,211 shares of CMPX stock, worth $961,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
259,211
Previous 304,504
14.87%
Holding current value
$961,672
Previous $578,000
16.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
106Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$56.5 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$50.1 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$37.2 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$26.5 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$24.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $376M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...